Using circulating tumor DNA to identify patients at risk of
Read more
wfamilymedicine.com
Home »
Using circulating tumor DNA to identify patients at risk of
Read more
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab),
Read more
A team of Roswell Park Comprehensive Cancer Center researchers has
Read more
Researchers studying a large set of small cell lung cancer
Read more
The interdisciplinary team of scientists from three different countries (Belgium,
Read more
A novel CAR T-cell therapy developed by researchers at UCL
Read more
Though cancer immunotherapy has become a promising standard-of-care treatment—and in
Read more
A ground-breaking new therapy that harnesses the body’s immune system
Read more
As early responders in the surveillance of malignant cells, natural
Read more
An international team involving Vanderbilt researchers has discovered that a
Read more